Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Jane Winter

She will lead the CRO's global consulting practice

INC Research CRO contract research Jane WinterINC Research has appointed industry veteran Jane Winter to lead its global consulting practice.

She has worked in the industry for 30 years of industry, most recently as interim global head of outsourcing at a Japanese biopharmaceutical company.

Earlier in her career Winter spent 11 years with Quintiles and three year with Wyeth (now part of Pfizer).

She currently serves on the board of directors for the Pan–Asian Clinical Research Association (PACRA), a non-profit organisation in Singapore dedicated to the professional development of clinical research personnel based in Asia Pacific.

As INC's senior vice president of global consulting Winter will be based in the UK and lead the CRO's unit that provides consulting in areas such as drug development and commercialisation and quality assurance.

Alistair Macdonald, INC's chief operating officer, said: “[Jane's] leadership and broad pharmaceutical background will be instrumental as we look to expand our integrated services model to include clinical development optimisation and compliance.

“These additions, combined with our strategy, QA and regulatory practice areas, provide the complete framework to address our customers' most pressing business needs in drug development today.”

26th February 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics